March 14, 2025 - 03:10

Battered by higher prescription drug costs and increased patient use of medical services, Highmark Health has reported significant financial losses in 2024. The organization revealed that its operating revenue took a substantial hit, primarily due to escalating expenses associated with pharmaceuticals and a surge in demand for healthcare services.
As more patients seek medical attention, the costs associated with providing care have risen sharply. This trend has placed additional strain on Highmark Health's financial resources, leading to an operating loss that has raised concerns among stakeholders. The increased utilization of healthcare services, coupled with the rising prices of prescription medications, has created a challenging environment for the organization.
Highmark Health's leadership is now tasked with navigating these turbulent waters, focusing on strategies to mitigate losses while continuing to provide essential services to its members. The organization is exploring various avenues to enhance operational efficiency and manage costs effectively in the face of these ongoing challenges.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...